Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Antheia uses synthetic biology to produce biosynthetic KSMs and APIs for essential medicines through engineered microbial fermentation.
Infinimmune operates as a biotechnology company.
Trial Library is an oncology clinical trials company.
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
Manus Bio develops an advanced fermentation technology to recreate plant processes in microorganisms.
Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response.
OverT Bio operates as a biotech company that provide cell therapy for cancers.
SyntaxBio develops genetic programming platform that can program cells without the need for consistent external intervention.
Curve Biosciences is a biotechnology company that focuses on precision medicine for chronic diseases.
OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.
Deep Learning x Synthetic Biology for Novel Protein Therapeutics
Integrated Biosciences develops next-generation therapeutics.
Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.
Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides at an unprecedented scale.
Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.
Aperiam Bio partners with enzyme engineers to create and share stabilized, solubilized, and catalytically optimized proteins.
Range Biotechnologies is creating tools to enable personalized health through translational proteomics.
Wyndly offers personalized prescription treatment and online care.
Ulab Systems develops a breakthrough software technology for digital dental treatment planning.
Klivo offers treatments for chronic diseases.
Alveo is a pre-clinical stage medical diagnostics company .
AI-powered mobile personal health assistant
Kit is an online seller of consumer products.
Singular Bio is a privately held company developing single molecule detection technology.
Civilization Ventures has invested in 51 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Civilization Ventures's top investment sectors include Health Care, Biotechnology, Life Science, Medical, Therapeutics. The firm invests across 25 different industry categories.
Among tracked funding rounds, Rocket Pharmaceuticals received $165.0M in a Post-IPO Equity round. Civilization Ventures's total known invested capital is $1.1B.
Civilization Ventures's average investment size is $24.3M across its portfolio of 51 companies.
Recent Civilization Ventures portfolio additions include Antheia, Infinimmune, Trial Library, Rocket Pharmaceuticals, Manus Bio. These companies were founded in 2020 or later.